Neogen (NEOG) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 21.09% |
| Nov 30, 2025 | 22.04% |
| Aug 31, 2025 | 23.03% |
| May 31, 2025 | 23.35% |
| Feb 28, 2025 | 30.17% |
| Nov 30, 2024 | 31.03% |
| Aug 31, 2024 | 36.55% |
| May 31, 2024 | 37.58% |
| Feb 29, 2024 | 38.39% |
| Nov 30, 2023 | 39.21% |
| Aug 31, 2023 | 40.16% |
| May 31, 2023 | 41.11% |
| Feb 28, 2023 | 41.98% |
| Nov 30, 2022 | 42.94% |
| Aug 31, 2022 | 12.66% |
| May 31, 2022 | 13.47% |
| Feb 28, 2022 | 14.15% |
| Nov 30, 2021 | 14.76% |
| Aug 31, 2021 | 15.44% |
| May 31, 2021 | 15.77% |
| Feb 28, 2021 | 15.80% |
| Nov 30, 2020 | 15.52% |
| Aug 31, 2020 | 15.48% |
| May 31, 2020 | 15.62% |
| Feb 29, 2020 | 16.15% |
| Nov 30, 2019 | 16.15% |
| Aug 31, 2019 | 15.67% |
| May 31, 2019 | 15.80% |
| Feb 28, 2019 | 16.32% |
| Nov 30, 2018 | 16.39% |
| Aug 31, 2018 | 16.52% |
| May 31, 2018 | 16.75% |
| Feb 28, 2018 | 17.14% |
| Nov 30, 2017 | 16.98% |
| Aug 31, 2017 | 16.27% |
| May 31, 2017 | 16.58% |
| Feb 28, 2017 | 16.55% |
| Nov 30, 2016 | 16.44% |
| Aug 31, 2016 | 16.28% |
| May 31, 2016 | 16.40% |
| May 31, 2015 | 18.03% |